Latest News

Canada legalizes marijuana

A Push for Drug Decriminalization Surges in Countries Around the World — Could the US be Next?

Washington, DC—(ENEWSPF)—August 7, 2018 By: Jag Davies Drug decriminalization has rapidly emerged as a mainstream political issue in Canada and several other countries, but few U.S. policymakers have embraced it so far. That could change soon. Ending criminal penalties for drug possession, often referred to as decriminalization, means nobody gets arrested,[Read More…]

DEA

How the US Drug War Fuels Migration, Violence and Trauma

Before blaming migrants for their plight, we must look at how the drug war creates violence and displacement CALIFORNIA—(ENEWSPF)—August 6, 2018 By: Eunisses Hernandez and Norma Palacios Last month, Marco Antonio Munoz, a 39-year-old Honduran asylum seeker died alone of suicide in his cell. The inescapable violence in Honduras — a substantial portion[Read More…]

FDA

FDA Encourages Development of Novel Medicines for Treatment of Opioid Abuse

Silver Spring, Maryland—(ENEWSPF)—August 6, 2018 By: Michael Felberbaum The U.S. Food and Drug Administration today issued new scientific recommendations aimed at encouraging more widespread innovation and development of novel medication-assisted treatment (MAT) drugs for the treatment of opioid use disorder (OUD). New draft guidance issued today outlines new ways for[Read More…]

Illinois Maple Tree

National Maple Tree Study the Subject of Sierra Club’s September 10 Meeting

MATTESON—(ENEWSPF)—August 6, 2018 By: Patrick Coffey The Sauk-Calumet Sierra Club Group will be resuming their monthly meetings (after the summer hiatus) on Monday, September 10th, at the Frankfort Public Library, 21119 Pfeiffer Rd. in Frankfort at 7:15 pm. The program at this meeting will be presented by Wendy Smith, Park Ranger at the Indiana[Read More…]

Competing drugmakers

How Rival Opioid Makers Sought To Cash In On Alarm Over OxyContin’s Dangers

CALIFORNIA—(ENEWSPF)—August 6, 2018 By: Fred Schulte As Purdue Pharma faced mounting criticism over deaths linked to OxyContin, rival drugmakers saw a chance to boost sales by stepping up marketing of similarly dangerous painkillers, such as fentanyl, morphine and methadone, Purdue internal documents reveal. Purdue’s 1996-2002 marketing plans for OxyContin, which[Read More…]

Most read stories this week

Take a Survey

ARCHIVES